Now, with data showing progesterone inhibition of tumor growth, it makes it reasonable to perform more detailed mechanistic studies to help define the interaction of nuclear progesterone receptor with nuclear FoxO1 activity in GBM. This evidence concerns the gene FOXO1 and neoplasm.